Recent Finacing
Recent Raise
Neurelis develops and commercializes noninvasive intranasal drug-delivery therapies for epilepsy and CNS disorders, commercializing VALTOCO (diazepam nasal spray) and advancing multiple pipeline candidates (NRL-2, NRL-3, NRL-4).
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
